Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Processa Pharmaceuticals, Inc. | Chief Executive Officer, Director | Common Stock | 87.2K | $69.5K | $0.80 | Jan 27, 2025 | George Ng IRRA FBO: George Ng |
Calidi Biotherapeutics, Inc. | Director | Common Stock | 18.5K | $33.4K | $1.80 | Sep 12, 2023 | Direct |
Calidi Biotherapeutics, Inc. | Director | Common Stock | 9.55K | $17.2K | $1.80 | Sep 12, 2023 | By Peng Ventures, LLC |
Processa Pharmaceuticals, Inc. | Chief Executive Officer, Director | Common Stock | 20K | $16K | $0.80 | Jan 27, 2025 | Ng Cha Family Trust |
TuHURA Biosciences, Inc./NV | Director | Options (Right to Buy) | 51.3K | Jan 2, 2025 | Direct | ||
Processa Pharmaceuticals, Inc. | Chief Executive Officer, Director | Warrants | 43.6K | Jan 29, 2025 | George Ng IRRA FBO: George Ng | ||
Kintara Therapeutics, Inc. | Director | Common Stock | 0 | Oct 18, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PCSA | Processa Pharmaceuticals, Inc. | Jan 27, 2025 | 2 | $0 | 4/A | Feb 18, 2025 | Chief Executive Officer, Director |
HURA | TuHURA Biosciences, Inc./NV | Jan 2, 2025 | 1 | $0 | 4 | Jan 6, 2025 | Director |
KTRA | Kintara Therapeutics, Inc. | Oct 18, 2024 | 3 | $0 | 4 | Oct 22, 2024 | Director |
KTRA | Kintara Therapeutics, Inc. | Oct 18, 2024 | 0 | $0 | 3 | Oct 22, 2024 | Director |
PCSA | Processa Pharmaceuticals, Inc. | Jan 30, 2024 | 1 | $27K | 4 | Jan 31, 2024 | Chief Executive Officer, Director |
PCSA | Processa Pharmaceuticals, Inc. | Oct 12, 2023 | 1 | $25K | 4 | Oct 12, 2023 | Chief Executive Officer, Director |
PCSA | Processa Pharmaceuticals, Inc. | Oct 10, 2023 | 1 | $25K | 4 | Oct 10, 2023 | Chief Executive Officer, Director |
CLDI | Calidi Biotherapeutics, Inc. | Sep 12, 2023 | 0 | $0 | 3 | Sep 25, 2023 | Director |
PCSA | Processa Pharmaceuticals, Inc. | Aug 8, 2023 | 2 | $0 | 4 | Aug 9, 2023 | Chief Executive Officer |
PCSA | Processa Pharmaceuticals, Inc. | Aug 8, 2023 | 0 | $0 | 3 | Aug 9, 2023 | Chief Executive Officer |